Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX), Vertex Pharmaceuticals (VRTX) and Ascendis Pharma (ASND)

TipRanksDec 23 21:41 · Ratings

Jefferies Maintains BioNTech(BNTX.US) With Buy Rating, Raises Target Price to $154.43

Futu NewsDec 21 02:31 · Ratings

BioNTech SE's Strategic and Clinical Advancements Drive Buy Rating on BNT327's Promise in Oncology

TipRanksDec 21 01:59 · Ratings

J.P. Morgan Maintains BioNTech(BNTX.US) With Hold Rating, Announces Target Price $122

Futu NewsDec 18 06:31 · Ratings

J.P. Morgan Reaffirms Their Hold Rating on BioNTech SE (BNTX)

TipRanksDec 18 05:35 · Ratings

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

MT NewswiresDec 17 23:57